Beijing Aosaikang Pharmaceutical Co., Ltd.
SZSE:002755.SZ
8.79 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -207.48 | -266.206 | 380.565 | 725.369 | 779.902 | 668.904 | 17.262 | 4.605 | 18.865 | 37.504 | 55.521 | 59.954 | 49.135 |
| Depreciation & Amortization
| 84.701 | 92.192 | 94.513 | 92.617 | 87.986 | 83.152 | 7.319 | 4.079 | 4.177 | 4.468 | 4.486 | 4.154 | 0 |
| Deferred Income Tax
| -2.255 | 0.316 | -2.2 | -5.831 | -3.476 | 3.735 | -0.889 | -0.6 | -2.092 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| 117.97 | 128.056 | 107.11 | -230.737 | -348.065 | -241.733 | -87.115 | 11.789 | -35.767 | -100.221 | -79.824 | 34.368 | 0 |
| Accounts Receivables
| 53.455 | 262.967 | 363.448 | 110.978 | -346.717 | -149.706 | -238.195 | 40.108 | 25.089 | 0 | 0 | 0 | 0 |
| Inventory
| -26.414 | -1.787 | 26.892 | 57.819 | -46.088 | -25.599 | 0.341 | 4.483 | -0.901 | 48.884 | -26.127 | 5.117 | 0 |
| Accounts Payables
| 93.184 | -133.441 | -281.03 | -393.704 | 48.216 | -70.162 | 285.28 | -32.201 | -57.862 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -7.344 | 0.316 | -2.2 | -5.831 | -3.476 | -216.133 | -87.456 | 7.306 | -34.866 | -149.105 | -53.697 | 29.251 | 0 |
| Other Non Cash Items
| 7.926 | -6.857 | -14.48 | -6.865 | 14.793 | -13.164 | 12.233 | -3.744 | 11.922 | 22.952 | 6.471 | 7.994 | -49.135 |
| Operating Cash Flow
| -26.568 | -52.815 | 567.708 | 580.384 | 534.616 | 497.159 | -50.302 | 16.73 | -0.803 | -35.297 | -13.345 | 106.47 | 0 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| -129.319 | -150.454 | -133.761 | -199.682 | -169.019 | -95.843 | -3.866 | -4.104 | -2.288 | -1.871 | -2.811 | -4.604 | -6.574 |
| Acquisitions Net
| 0.592 | 0.884 | 0.942 | 199.691 | -7.597 | -62.091 | -35.702 | 0.023 | 0.527 | 1.962 | 0 | 0 | 0.207 |
| Purchases Of Investments
| -3,183 | -3,559 | -1,533 | -376 | -513 | -2,744.9 | -59 | 0 | 0 | -20 | 0 | 0 | -5 |
| Sales Maturities Of Investments
| 3,323.289 | 3,269.654 | 1,102.795 | 359.933 | 394.35 | 2,735.118 | 59.007 | 0 | 0 | 20.229 | 0 | 0 | 5.014 |
| Other Investing Activites
| 140.881 | 0 | 0 | -199.682 | 0.884 | 25.947 | 0.315 | 0.023 | 0.527 | -1.871 | 0.016 | 0.016 | 0.006 |
| Investing Cash Flow
| 11.563 | -438.916 | -563.025 | -215.739 | -294.383 | -141.77 | -39.247 | -4.081 | -1.761 | -1.552 | -2.795 | -4.588 | -6.347 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| -89 | -45 | -20 | -22.439 | -8 | -15 | -29.043 | -29.152 | -25 | 0 | 0 | -100 | 0 |
| Common Stock Issued
| 0 | 0 | 1.601 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -1.601 | -0.07 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -1.125 | -92.816 | -185.632 | -204.195 | -111.379 | -0.488 | -1.216 | -3.547 | -7.601 | -11.46 | -11.34 | -11.4 | -7.6 |
| Other Financing Activities
| 203.299 | 214.105 | -3.982 | 22.439 | 0.014 | 0.037 | 35.333 | -0.002 | 163.47 | 0 | 0 | 3.89 | 0 |
| Financing Cash Flow
| 291.174 | 75.912 | -209.738 | -182.824 | -124.717 | -15.451 | 5.074 | -3.547 | 155.869 | -11.46 | -11.34 | -11.4 | -7.6 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| -1.2 | 15.597 | -0.019 | -0.062 | 0.015 | 0.045 | 0.082 | 0 | 0.036 | 0 | -0 | 0 | 0 |
| Net Change In Cash
| 274.968 | -400.222 | -205.075 | 181.76 | 115.532 | 339.983 | -84.393 | 9.102 | 153.305 | -48.309 | -27.48 | 90.482 | 19.346 |
| Cash At End Of Period
| 1,035.644 | 760.676 | 1,160.898 | 1,365.973 | 1,184.213 | 1,068.681 | 178.887 | 263.28 | 254.178 | 100.873 | 149.182 | 176.662 | 86.18 |